NVIDIA discrete GPU market share expands to 94% in Q2 2025

Analyst firm Jon Peddie Research reports that NVIDIA accounted for 94% of discrete AIB shipments in Q2 2025, a 2.1% increase quarter over quarter as AMD ceded share. The report ties the gain to NVIDIA´s mid-range Blackwell rollout and notes a broader rebound in AIB shipments to 11.6 million units.

According to a report from Jon Peddie Research, NVIDIA captured 94% of discrete add-in board shipments in Q2 2025, up 2.1 percentage points from roughly 92% in the prior quarter. The firm notes that AMD lost the corresponding 2.1% share during the same period, indicating that those AIB sales shifted to NVIDIA. The report attributes part of NVIDIA´s gain to the rollout of mid-range Blackwell GPUs, which now cover budget tiers across the market, while AMD´s RDNA 4 lineup is described as focused on the mid-range segment and therefore less competitive at the high end.

The report also highlights that current GPU generation rollouts are effectively complete and that Intel holds less than 1% market share among AIB vendors. Overall market volumes rebounded to 11.6 million units in Q2, a notable increase compared to recent seasonality. Jon Peddie Research states that this quarter´s shipments were up from the 10-year average of 5.7%. The firm characterizes the AIB GPU market as in a healthy state given the shipment rebound and the consolidation of share among the primary suppliers.

Dr. Jon Peddie, president of Jon Peddie Research, is quoted on pricing and inventory dynamics. He reports that mid-range and entry-level AIB prices dropped while high-end AIB prices increased, and that most retail suppliers ran out of stock, an outcome the firm calls unusual for the second quarter. The report suggests these trends may reflect expectations of higher prices driven by tariffs and buyers attempting to secure inventory ahead of potential cost increases.

63

Impact Score

HMS researchers design Artificial Intelligence tool to quicken drug discovery

Harvard Medical School researchers unveiled PDGrapher, an Artificial Intelligence tool that identifies gene target combinations to reverse disease states up to 25 times faster than current methods. The Nature-published study outlines a shift from single-target screening to multi-gene intervention design.

How hackers poison Artificial Intelligence business tools and defences

Researchers report attackers are now planting hidden prompts in emails to hijack enterprise Artificial Intelligence tools and even tamper with Artificial Intelligence-powered security features. With most organisations adopting Artificial Intelligence, email must be treated as an execution environment with stricter controls.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.